Efficacy of Single Shot GnRH versus CIDR-PGF2α-GnRH-FTAI Protocol for the Treatment of Postpartum True Anestrus in Dairy Cattle
DOI:
https://doi.org/10.3126/jafu.v7i1.95385Keywords:
Estrus induction, fixed-time artificial insemination, hormonal protocols, infertility, pregnancyAbstract
Postpartum true anestrus is a major cause of reduced fertility and production, particularly in high-yielding crossbred dairy cows. Hormonal interventions under proper nutrition and management can restore reproductive function. This study compared two hormonal protocols for treating postpartum true anestrus in dairy cows. Forty-five postpartum anestrous cows were examined by transrectal palpation and ultrasonography to classify them as true anestrus or silent estrus. Among these, 73.3% had true anestrus and were included in the treatment trial (n=33). In treatment 1 (GnRH, n=13), cows received a single intramuscular injection of buserelin acetate (20 μg). In treatment 2 (CIDR-PGF2α-GnRH-FTAI, n=20), a CIDR device containing 1.9 g progesterone was inserted on day 0 and removed on day 7, with PGF2α (cloprosterol 500 μg) injected at removal. GnRH (20 μg) was administered on day 9, followed by fixed-time artificial insemination on day 10. Estrus induction rate did not differ significantly between GnRH (53.9%) and CIDR-PGF2α-GnRH-FTAI (60%) groups. The interval from treatment to estrus was shorter in the CIDR-based group (61.0±10.2 h) than in the GnRH group (163.7±36.0 h). Pregnancy rate tended to be higher in CIDR-PGF2α-GnRH-FTAI (55.0%) than in GnRH (23.1%, P=0.07). Cows with good body condition score (BCS) had higher pregnancy rate than those with poor BCS (P=0.05). Other factors, including milk yield, endoparasitic infection and anemia, had no significant effect. Single-shot GnRH was as effective as CIDR-PGF2α-GnRH-FTAI for estrus induction, while the CIDR-based protocol shortened the interval to estrus and tends to improve pregnancy outcomes.
Downloads
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.